Navigation Links
Volcano Presentation at Thomas Weisel Conference to Be Webcast
Date:8/28/2008

SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4.

The presentation by Scott Huennekens, president and chief executive officer, will begin at 3:50 p.m., Eastern Daylight Time (12:50 p.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.veracast.com/webcasts/twp/healthcare08/54213429.cfm or via the company's website at http://www.volcanocorp.com.

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) tissue characterization and ChromaFlo(R). Volca
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
2. Volcano Announces Acquisition of Novelis, Inc.
3. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
4. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
5. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
6. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
9. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
10. Volcano Announces Closing of CardioSpectra Acquisition
11. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... have developed a simple, cheap, accurate test to find ... have created a custom-made bacteria that glows green when ... explosives. , The bacteria can be mixed into a ... forms green patches to indicate the presence of landmines. ... cheap to produce, could be delivered from the air ...
(Date:12/16/2009)... Dec. 16 Martek Biosciences Corporation (Nasdaq: ... fourth quarter and fiscal year ended October 31, 2009. ... 3% from $90.4 million in the fourth quarter of ... per diluted share, for the fourth quarter of fiscal ... $0.31 per diluted share, in last year,s fourth quarter. ...
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... ultimate CHO cell culture supplement? InVitria has what scientists have ... media supplement that improves the growth and productivity of CHO ... Zap-CHO is an animal free, well defined and consistent recombinant ... ... CO (PRWEB) December 16, 2009 -- Scientists working with CHO ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
... GE Healthcare announced today that Rockwood ... facilities in the Spokane, Washington area, has purchased a ... of the new technologies the clinic is installing is ... appointments, update their patient profile and make co-payments electronically. ...
... (Commerce) has qualified five small businesses for investor tax ... Tax Credit Programs. , ,"By encouraging investors through tax ... to turn these great ideas into viable, job-creating businesses," ... and Venture Fund Tax Credit Programs offer Wisconsin income ...
... National Committee for Quality Assurance (NCQA) has ... as the first electronic health record (EHR) software shown ... American Diabetes Association Diabetes Physician Recognition Program (DPRP). ... required to pull a random sample of their patient ...
Other Biology Technology:Five technology companies qualify for investor tax credits 2
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
(Date:12/15/2009)... available in German ., Despite the ... the globe, cultures vary as to how space is ... use egocentric terms such as ,left, right, front, back, ... like ,north, south, east, west, at all times for ... or "There is an snake by your Northern leg". ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3More than a jump to the left 2Are Microbes Headed Back to School this Fall 3F 53556 1Are Microbes Headed Back to School this Fall 3F 53556 2Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 1Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 2Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 3Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 4Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 5Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 6Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 7Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 8Surgical Masks Help Ward Off Flu Maybe 53553 1Surgical Masks Help Ward Off Flu Maybe 53553 2Surgical Masks Help Ward Off Flu Maybe 53553 3Surgical Masks Help Ward Off Flu Maybe 53553 4
... growing faster than anywhere else in the world. This is ... urban environment and effect of cities on rural areas. One ... being over-looked. , Joy Clancy from the University of Twente ... African Journal of Ecology . She says "A hundred ...
... climate change, pollution and human activity. ESA,s ERS and ... region for the last 17 years. These long term ... be key in implementing the newly adopted European Commission ... , The policy highlights new opportunities in the region ...
... fish are prompting widespread consumption advisories and uncertainty among ... researchers at North Carolina State University have developed a ... country predict which areas are likely to have fish ... help officials address public uncertainty by developing health advisories ...
Other Biology News:ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2
...
...
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...
... was developed using a protein engineering approach that ... pocket of wild-type DNase I. These changes markedly ... The result is a versatile enzyme that has ... ability to maintain at least 50% of peak ...
Biology Products: